Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
World Journal of Clinical Oncology|August 30, 2017
Use of programmed cell death protein ligand 1 assay to predict the outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitorsCarmelo Tibaldi, Alice Lunghi, Editta BaldiniNanomaterials (Basel, Switzerland)|August 27, 2021
Evaluation of the In Vitro Biocompatibility of PEDOT:Nafion CoatingsSonia Guzzo, Stefano Carli, Barbara Pavan, et al.Cancer|September 30, 2011
Sunitinib-induced hyperparathyroidism: a possible mechanism to altered bone homeostasisValentina Baldazzi, Renato Tassi, Alberto Lapini, et al.Anticancer Research|February 11, 2014
Complete pathological response in advanced extra-gastrointestinal stromal tumor after imatinib mesylate therapy: a case reportMattia Rediti, Elisa Pellegrini, Elena Molinara, et al.Tumori|April 25, 2015
Outcome of crizotinib treatment in a young woman with heavily pretreated ROS1-positive lung cancerPaolo Petreni, Francesca Mazzoni, Giulia Meoni, et al.Journal of Materials Chemistry. B|May 2, 2025
Magnetic diatom shells: nature's blueprint for cellular transportAlice Lunghi, Danilo Vona, Stefania Roberta Cicco, et al.ACS Applied Materials & Interfaces|December 13, 2023
Synergy of Nanotopography and Electrical Conductivity of PEDOT/PSS for Enhanced Neuronal DevelopmentMichele Bianchi, Sonia Guzzo, Alice Lunghi, et al.Nanotechnology|September 27, 2024
Fabrication and characterization of bioresorbable, electroactive and highly regular nanomodulated cell interfacesAlice Lunghi, Federica Velluto, Luana Di Lisa, et al.Frontiers in Physiology|September 5, 2022
PEDOT: PSS promotes neurogenic commitment of neural crest-derived stem cellsAlessandra Pisciotta, Alice Lunghi, Giulia Bertani, et al.Anti-Cancer Drugs|June 27, 2020
Somatostatin analogs in pregnant patients with neuroendocrine tumorGiulia Meoni, Elisa Giommoni, Paolo Petreni, et al.Pageof 2